Caleres Regular Quarterly Dividend
Get Alerts CAL Hot Sheet
Join SI Premium – FREE
ST. LOUIS--(BUSINESS WIRE)-- The quarterly dividend for Caleres (NYSE: CAL) (caleres.com) of $0.07 per share, will be payable on July 1, 2019, to shareholders of record as of June 17, 2019.
This dividend will be the 385th consecutive quarterly dividend paid by the company.
About Caleres
Caleres is a diverse portfolio of global footwear brands. Our products are available virtually everywhere - in the over 1,200 retail stores we operate, in hundreds of major department and specialty stores, on our branded e-commerce sites, and on many additional third-party retail websites. Famous Footwear offers great brands for the entire family with convenient, curated, affordable collections. Sam Edelman keeps expressive women in step with the latest trends in a playful, whimsical way. Naturalizer shoes are beautiful from the inside out, with elegant simplicity and legendary fit re-imagined for today’s consumer. Allen Edmonds combines old world craft with new world technology to create luxe footwear for the discerning man who wants sophisticated, modern classics. Rounding out our family of brands are Vionic, Dr. Scholl’s Shoes, Vince, Franco Sarto, LifeStride, Via Spiga, Blowfish Malibu, Bzees, Circus by Sam Edelman, Fergie and Ryka. Combined, these brands make Caleres a company with both a legacy and a mission. Our legacy is our more than 140 years of craftsmanship and our passion for fit, while our mission is to continue to inspire people to feel great… feet first. Visit caleres.com to learn more about us.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190531005474/en/
Investor and Media Contact:
Peggy Reilly Tharp, Caleres
(314)
854-4134, [email protected]
Source: Caleres
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gores Holdings XI, Inc. Announces Pricing of $312 Million Initial Public Offering
- Shenzhen HQVT Technology Lists on HKEX Main Board, Accelerating Implementation of Multispectral AI Technology
- Sagimet Biosciences Announces Participation in Upcoming Investor Conference and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share